AsortinoBeta
Bristol-Myers Squibb Company logo

BMYBristol-Myers Squibb Company

NYSEStockHealthcareDrug Manufacturers - General🇺🇸 United StatesISIN US1101221083bms.com
$66.821.87%
NYSE · at close Sep 4, 2026
Tokenized by
Reality logoBacked Finance logoDinari Inc. logo
3 issuersOn
Arbitrum One logoSolana logoEthereum logoXLayer logo
14 chains

Chart data are delayed by 15 minutes.

1D1.87%
1M+1.41%
3M+18.06%
1Y+43.11%
3Y+7.74%
5Y+1.84%

Main metrics

$136.49B
$488.39<0.01% of mkt cap
14.72
$4.54
3.76%
10.6M
0.23
$42.5252-week range$68.64

About BMY

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving patients with complex and often chronic conditions. Its portfolio includes small-molecule drugs, biologics, and cell therapies, reflecting a broad approach to advanced treatment design and delivery. The company supports healthcare systems through research-driven products used in hospitals, specialty clinics, and outpatient care settings around the world. Bristol-Myers Squibb Company plays an important role in the pharmaceutical market by providing therapies aimed at difficult-to-treat illnesses and by maintaining a diversified pipeline and product mix across multiple disease categories.

Similar products

AbbVie Inc. logo
ABBVNYSE
$256.461.44%
AbbVie Inc.
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 15 chains
Amgen Inc. logo
AMGNNASDAQ
$437.231.55%
Amgen Inc.
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 14 chains
Biogen Inc. logo
BIIBNASDAQ
$220.831.64%
Biogen Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Gilead Sciences, Inc. logo
GILDNASDAQ
$151.000.15%
Gilead Sciences, Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains